SU JOK FOR DYSPNEA AND FATIGUE

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disease characterized by persistent airflow limitation and symptoms such as dyspnea and fatigue, which substantially impair patients' functional capacity and quality of life. Although pharmacological treatment is the cornerstone of COPD management, complementary non-pharmacological interventions may provide additional benefits in symptom control.

Su Jok therapy is a complementary therapy based on the stimulation of corresponding points on the hands and feet. It has been proposed as a simple, non-invasive, and low-cost intervention that may help reduce symptom severity and improve patient well-being. However, evidence regarding its effectiveness in patients with COPD is limited.

This study is designed as a randomized controlled trial to evaluate the effects of Su Jok therapy on dyspnea and fatigue in patients with COPD. Eligible participants will be randomly assigned to either an intervention group receiving Su Jok therapy in addition to routine care or a control group receiving routine care alone. Dyspnea and fatigue will be assessed using validated measurement instruments before and after the intervention. The primary objective is to determine whether Su Jok therapy provides additional benefits in reducing dyspnea and fatigue compared with routine care alone. The findings are expected to contribute to the evidence base regarding complementary therapies in COPD management and to support evidence-based nursing practice.

Inclusion criteria

Adults aged 18 years or older. Diagnosed with chronic obstructive pulmonary disease (COPD). Able to communicate verbally. Expected to remain hospitalized for at least 5 days to ensure completion of the intervention.

No major health condition other than COPD that could adversely affect activities of daily living (e.g., open wounds, cancer, or gastrointestinal disorders).

Provided written informed consent to participate in the study. A Visual Analog Scale (VAS) score of 3 or higher for dyspnea and fatigue

Exclusion criteria

Patients who do not provide written informed consent to participate in the study.

Patients who are unable to communicate verbally. Patients with conditions that would prevent the application of Su Jok therapy to the hands, such as neuropathy, amputation, open wounds, or other hand disorders.